CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Millions	Total	Total Dentsply Sirona Equity	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interests
Beginning Balance at Dec. 31, 2020	$ 4,935	$ 4,932	$ 3	$ 6,604	$ 1,198	$ (464)	$ (2,409)	$ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	112	112			112
Other Comprehensive (loss) income	(90)	(90)				(90)
Exercise of stock options	33	33		11			22
Stock based compensation expense	13	13		13
Funding of employee stock purchase plan	3	3		1			2
Treasury shares purchased	(90)	(90)					(90)
Restricted stock unit distributions	(4)	(4)		(11)			7
Cash dividends	(22)	(22)			(22)
Ending Balance at Mar. 31, 2021	4,890	4,887	3	6,618	1,288	(554)	(2,468)	3
Beginning Balance at Dec. 31, 2020	4,935	4,932	3	6,604	1,198	(464)	(2,409)	3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	292
Other Comprehensive (loss) income	(103)
Ending Balance at Sep. 30, 2021	5,063	5,060	3	6,659	1,419	(567)	(2,454)	3
Beginning Balance at Mar. 31, 2021	4,890	4,887	3	6,618	1,288	(554)	(2,468)	3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	96	96			96
Other Comprehensive (loss) income	43	43				43
Exercise of stock options	12	12		3			9
Stock based compensation expense	19	19		19
Restricted stock unit distributions	(1)	(1)		(2)			1
Cash dividends	(25)	(25)			(25)
Ending Balance at Jun. 30, 2021	5,034	5,031	3	6,638	1,359	(511)	(2,458)	3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	84	84			84			0
Other Comprehensive (loss) income	(56)	(56)				(56)
Exercise of stock options	1	1					1
Stock based compensation expense	23	23		23
Funding of employee stock purchase plan	3	3		1			2
Restricted stock unit distributions	(3)	(3)		(4)			1
Restricted stock unit dividends	0	0		1	(1)
Cash dividends	(23)	(23)			(23)
Ending Balance at Sep. 30, 2021	5,063	5,060	3	6,659	1,419	(567)	(2,454)	3
Beginning Balance at Dec. 31, 2021	4,997	4,996	3	6,606	1,514	(592)	(2,535)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	69	69			69
Other Comprehensive (loss) income	(37)	(37)				(37)
Exercise of stock options	5	5		1			4
Stock based compensation expense	11	11		11
Funding of employee stock purchase plan	2	2		1			1
Accelerated share repurchase	(150)	(150)		(30)			(120)
Restricted stock unit distributions	(6)	(6)		(16)			10
Cash dividends	(27)	(27)			(27)
Ending Balance at Mar. 31, 2022	4,864	4,863	3	6,573	1,556	(629)	(2,640)	1
Beginning Balance at Dec. 31, 2021	4,997	4,996	3	6,606	1,514	(592)	(2,535)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(935)
Other Comprehensive (loss) income	(252)
Ending Balance at Sep. 30, 2022	3,614	3,613	3	6,619	498	(844)	(2,663)	1
Beginning Balance at Mar. 31, 2022	4,864	4,863	3	6,573	1,556	(629)	(2,640)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	73	73			73
Other Comprehensive (loss) income	(90)	(90)				(90)
Exercise of stock options	2	2					2
Stock based compensation expense	16	16		16
Funding of employee stock purchase plan	1	1					1
Accelerated share repurchase	0	0		30			(30)
Restricted stock unit distributions	(2)	(2)		(3)			1
Restricted stock unit dividends				1	(1)
Cash dividends	(26)	(26)			(26)
Ending Balance at Jun. 30, 2022	4,838	4,837	3	6,617	1,602	(719)	(2,666)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(1,077)	(1,077)			(1,077)
Other Comprehensive (loss) income	(125)	(125)				(125)
Stock based compensation expense	3	3		3
Funding of employee stock purchase plan	3	3					3
Restricted stock unit distributions	(1)	(1)		(1)
Restricted stock unit dividends	0	0
Cash dividends	(27)	(27)			(27)
Ending Balance at Sep. 30, 2022	$ 3,614	$ 3,613	$ 3	$ 6,619	$ 498	$ (844)	$ (2,663)	$ 1